Åslaug Helland

Overlege
ved Avdeling for kreftbehandling ved Oslo universitetssykehus HF
Professor
ved Forskningsleder KRE ved Universitetet i Oslo

Resultater Resultater

Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study.

Miceli, Rosalba; Eriksson, Hanna; Lo Russo, Giuseppe; Alfieri, Salvatore; Bjaanæs, Maria Moksnes; Pietrantonio, Filippo; De Cecco, Loris; Prelaj, Arsela; Proto, Claudia; Franzén, Johan mfl.. 2024, Acta Oncologica. CRO, UIO, OUS, TUoDTC, SVERIGEVitenskapelig artikkel

Small Cell Lung Cancer in Norway: Patterns of Care by Health Region and Survival Trends.

Nilssen, Yngvar; Brustugun, Odd Terje; Fjellbirkeland, Lars; Grønberg, Bjørn Henning; Haram, Per Magnus; Helbekkmo, Nina; Helland, Åslaug; Wahl, Sissel Gyrid Freim; Aanerud, Marianne; Solberg, Steinar. 2024, Clinical Lung Cancer. VV, UNN, STOLAV, NTNU, HAUKELAND, UIO, OUS, KREFTREG, UIBVitenskapelig artikkel

Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma.

Brativnyk, Anastasia; Ankill, Jørgen; Helland, Åslaug; Fleischer, Thomas. 2024, International Journal of Cancer. UIO, OUSVitenskapelig artikkel

UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma – A phase II randomised trial.

Haakensen, Vilde Drageset; Öjlert, Åsa Kristina; Thunold, Solfrid; Farooqi, Saima Jamil; Nowak, Anna K.; Chin, Wee L.; Grundberg, Oscar; Szejniuk, Weronika Maria; Cedres, Susana; Sørensen, Jens Benn mfl.. 2024, European Journal of Cancer. KAROLINSKA, AAU, RH, SCGH, UIO, KU, SPANIA, OUS, UWA, KI, AARHUSSYKEVitenskapelig artikkel

Distribution and characteristics of malignant tumours by lung lobe.

Nilssen, Yngvar; Brustugun, Odd Terje; Fjellbirkeland, Lars; Helland, Åslaug; Møller, Bjørn; Wahl, Sissel Gyrid Freim; Solberg, Steinar. 2024, BMC Pulmonary Medicine. VV, STOLAV, UIO, OUS, KREFTREGVitenskapelig artikkel